XML 90 R83.htm IDEA: XBRL DOCUMENT v3.20.1
Subsequent Events - Additional Information (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2020
USD ($)
May 30, 2018
ft²
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2020
Jan. 01, 2019
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Deferred revenue recognized       $ 439,000 $ 344,000 $ 143,000 $ 14,434,000 $ 9,764,000 $ 1,730,000 $ 2,428,000 $ 45,495,000 $ 15,360,000 $ 59,417,000 $ 12,826,000    
Type of Revenue [Extensible List]       us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember us-gaap:CollaborativeArrangementMember    
Operating lease, right-of-use asset       $ 14,858,000               $ 14,858,000       $ 16,672,000
Operating lease liabilities       $ 19,930,000               $ 19,930,000        
Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease term       10 years               10 years        
Lease Amendment | Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease term, description   In May 2018, the Company executed an amendment to lease an additional 33,526 square feet at 50 Hampshire Street in Cambridge, Massachusetts, with a 10-year term. This additional space became available for occupancy on January 1, 2020                            
Land subject to additional ground leases | ft²   33,526                            
Lease term   10 years                            
Scenario, Forecast | Employee Severance | Operating Expenses                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Severance Costs     $ 1,272,000                          
Maximum | Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease term       10 years               10 years        
Minimum | Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease term       1 year               1 year        
Novartis Collaboration | Novartis Institutes for Biomedical Research, Inc.                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Type of Revenue [Extensible List]                       us-gaap:CollaborativeArrangementMember        
Novartis Collaboration | Novartis Institutes for Biomedical Research, Inc. | Scenario, Forecast                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Deferred revenue recognized     $ 38,592,000                          
Sublease agreement with EQRx | Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Term of contract                       The term of the sublease agreement commenced in January 2020 and ends on the last day of the 36th calendar month following commencement.        
Sublease agreement with EQRx | Massachusetts | Office Space                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease commenced date                       Jan. 01, 2020        
Sublease agreement with EQRx | Lease Amendment | Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease term, description   In May 2018, the Company executed an amendment to lease an additional 33,526 square feet at 50 Hampshire Street in Cambridge, Massachusetts, with a 10-year term.                            
Land subject to additional ground leases | ft²   33,526                            
Lease term   10 years                            
Sublease agreement with EQRx | Scenario, Forecast | Massachusetts | Office Space                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Lease term                             3 years  
Subsequent Event | Employee Severance                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Percentage of reduction of company's workforce 35.00%                              
Subsequent Event | Sublease agreement with EQRx | Massachusetts                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Operating lease, right-of-use asset $ 15,003,000                              
Operating lease liabilities 15,003,000                              
Milestone Payment | Novartis Collaboration | Novartis Institutes for Biomedical Research, Inc. | Maximum                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Maximum aggregate amount of potential option purchase, option exercise and milestone payments to be currently received       $ 745,000,000               $ 745,000,000        
Milestone Payment | Subsequent Event | Novartis Collaboration | Novartis Institutes for Biomedical Research, Inc. | Maximum                                
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                                
Maximum aggregate amount of potential option purchase, option exercise and milestone payments to be currently received $ 525,000,000